KFDA to face damage suit from pharmaceutical companies

Published: 2009-04-16 06:59:00

Updated: 2009-04-16 06:59:00

Members of the Korea Pharmaceutical Manufacturers Association said 14 that it would file a joint suit against the Korea Food and Drug Administration for having hastily banned sales of drugs without a thorough investigation, which caused an alleged hundreds of billions of won in losses.

“We ha...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK